Enhancing ADC Patient Selection Through Digitally Quantified Biomarkers & Morphology
Time: 9:00 am
day: Conference Day One
Details:
- Describe how digital pathology may improve the quantification of biomarkers to more accurately identify patients most likely to benefit from ADC therapies
- Define tumor morphologic features, tumor cell and TME-related, that should be assessed as the field works to expand its understanding of predictive biomarkers for ADC therapies
- Discuss how AI-driven image analysis may support more nuanced stratification in tumors with heterogeneous target expression
